Cargando…
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
Zoledronic acid (ZA) is one of the most important and effective class of anti-resorptive drug available among bisphosphonate (BP), which could effectively reduce the risk of skeletal-related events, and lead to a treatment paradigm for patients with skeletal involvement from advanced cancers. Howeve...
Autores principales: | Wang, Lianwei, Fang, Dengyang, Xu, Jinming, Luo, Runlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607850/ https://www.ncbi.nlm.nih.gov/pubmed/33143662 http://dx.doi.org/10.1186/s12885-020-07568-9 |
Ejemplares similares
-
Pleomorphic liposarcoma: An analysis of 6 case reports and literature review
por: Wang, Lianwei, et al.
Publicado: (2018) -
Primary Pleomorphic Liposarcoma of Fallopian Tube with Recurrence: A Case Report and Review of the Literature
por: Wang, Lianwei, et al.
Publicado: (2017) -
Large Brunner’s gland adenoma of the duodenum for almost 10
years
por: Yang, Bo, et al.
Publicado: (2020) -
How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022) -
Inhibition of the hedgehog pathway for the treatment of cancer using Itraconazole
por: Li, Ke, et al.
Publicado: (2019)